881624209TEVA PHARMACEUTICAL INDS LTD
CUSIP 881624209 · depositary receipt
No tracked investor reported shares of TEVA PHARMACEUTICAL INDS LTD (881624209) for Q3 2026. 7 investors sold out this quarter, including Harry Burn.
Holders · Q3 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding 881624209 · Q3 2026
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Harry Burn | 3.97% | 3,804,497 | $128.9M | EXIT |
| David Einhorn | 2.50% | 2,886,059 | $97.8M | EXIT |
| Stanley Druckenmiller | 0.41% | 624,999 | $21.2M | EXIT |
| Adar1 Capital Management | 0.43% | 277,848 | $9.4M | EXIT |
| Ron Baron | 0.01% | 138,987 | $4.7M | EXIT |
| Cathie Wood | 0.02% | 68,653 | $2.3M | EXIT |
| Mario Gabelli | 0.02% | 66,100 | $2.2M | EXIT |
History
| Quarter | Holders | New | Sold out | Value held | Quarter-end price (est.) |
|---|---|---|---|---|---|
| Q3 2026 | 0 | 0 | 7 | $0 | — |
| Q2 2026 | 7 | 0 | 0 | $266.5M | $33.88 |
| Q1 2026 | 7 | 0 | 0 | $292.4M | $30.12 |
| Q4 2025 | 7 | 0 | 0 | $430.4M | $31.21 |
| Q4 2021 | 0 | 0 | 1 | $0 | — |
| Q3 2021 | 1 | 0 | 0 | $416.8M | $9.74 |
| Q2 2021 | 1 | 0 | 0 | $423.6M | $9.90 |
| Q1 2021 | 1 | 0 | 0 | $493.8M | $11.54 |
| Q4 2020 | 1 | 0 | 0 | $412.9M | $9.65 |
| Q3 2020 | 1 | 0 | 0 | $385.5M | $9.01 |
| Q2 2020 | 1 | 0 | 0 | $527.6M | $12.33 |
| Q1 2020 | 1 | 0 | 0 | $384.2M | $8.98 |
| Q4 2019 | 1 | 0 | 0 | $423.8M | $9.80 |
| Q3 2019 | 1 | 0 | 0 | $297.6M | $6.88 |
| Q2 2019 | 1 | 0 | 0 | $399.2M | $9.23 |
| Q1 2019 | 1 | 0 | 0 | $678.1M | $15.68 |
| Q4 2018 | 1 | 0 | 0 | $666.9M | $15.42 |
| Q3 2018 | 1 | 0 | 0 | $931.6M | $21.54 |
| Q2 2018 | 1 | 0 | 0 | $1.1B | $24.32 |
| Q1 2018 | 1 | 0 | 0 | $692.8M | $17.09 |
| Q4 2017 | 1 | 1 | 0 | $357.7M | $18.95 |